Operation of the Audit Committee:
In the most recent year (2023) the Audit Committee convened 7 meetings. The attendance of independent directors is as follows:
|
Title |
Name |
Actual Attendance |
Entrusted to Attend Frequency |
Attendance Rate (%) |
|---|---|---|---|---|
|
Independent Director |
Yang Yung Cheng |
7 |
0 |
100.00 |
|
Independent Director |
Lee Wen Chuan |
7 |
0 |
100.00 |
|
Independent Director |
Juan Chiung Hua |
7 |
0 |
100.00 |
|
Independent Director |
Ho Chia Fang |
7 |
0 |
100.00 |
Discussion items and resolutions:
The matters listed in Article 14(5) of Securities and Exchange Act:
|
Session |
Date |
Meeting Content |
Resolution |
|---|---|---|---|
|
6th time of the 5th committee |
2023.02.07 |
Factory construction through the Indonesian joint venture PT All Cosmos Biotek (PT Biotek) |
All Directors approved |
|
7th time of the 5th committee |
2023.03.22 |
1.2022 consolidated financial statements and business report proposal 2.2022 surplus distribution plan 3.2022 Internal Control System Statement 4.Accountant Remuneration and Competency in 2023 5.Pre-approval policy for accountants’ non assurance services 6.Subsidiary ACI plans to establish Eckare Malaysia Sdn.Bhd., a joint venture company in Malaysia with Eastern E-Commerce Co., Ltd |
All Directors approved |
|
8th time of the 5th committee |
2023.05.11 |
Consolidated Financial Statements for the First Quarter of 2023 |
All Directors approved |
|
9th time of the 5th committee |
2023.08.01 |
YPJ to increase the shareholding ratio of jointly invested Indonesian subsidiary PTACB |
All Directors approved |
|
10th time of the 5th committee |
2023.08.25 |
Consolidated Financial Statements for the Second Quarter of 2023 |
All Directors approved |